Boston Scientific to Present at Bernstein Conference, Q2 2026 Earnings Call
Event summary
- Boston Scientific will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 27, 2026, with CEO Mike Mahoney and CMO Janar Sathananthan.
- The company will host a Q2 2026 earnings call on July 29, 2026, led by CEO Mike Mahoney and CFO Jon Monson.
- Financial results for Q2 2026 will be released on July 29, 2026, prior to the earnings call.
- Live webcasts and replays for both events will be available on Boston Scientific's investor relations website.
The big picture
Boston Scientific's participation in Bernstein's conference and upcoming earnings call come at a time when the medical technology sector is under pressure to demonstrate sustainable growth amid regulatory and reimbursement challenges. The company's focus on innovative solutions for complex diseases positions it within broader industry trends toward value-based healthcare. Investors will be watching for signals on how Boston Scientific plans to navigate these dynamics while maintaining profitability.
What we're watching
- Strategic Messaging
- How Boston Scientific frames its long-term growth strategy and innovation pipeline during the Bernstein conference.
- Financial Guidance
- Whether Q2 2026 results and forward-looking guidance meet or exceed analyst expectations.
- Market Positioning
- The pace at which Boston Scientific can differentiate itself in competitive medical technology segments.
Related topics